Refine
Has Fulltext
- yes (13)
Is part of the Bibliography
- yes (13)
Document Type
- Journal article (12)
- Doctoral Thesis (1)
Keywords
- COVID-19 (3)
- acute respiratory distress syndrome (2)
- perioperative care (2)
- postoperative nausea and vomiting (2)
- ARDS (acute respiratory distress syndrome) (1)
- Anastomoseninsuffizienz (1)
- COVID-19-Pademie (1)
- Coronavirus Disease 2019 (1)
- ECMO-Therapie (1)
- Fibroblast (1)
- Fibroblasts (1)
- Gastrointestinaltrakt (1)
- Geburtshilfe (1)
- Geburtshilfliche Intensivmedizin (1)
- Germany (1)
- Infektionswellen (1)
- Magen (1)
- Magenchirurgie (1)
- Magenkrankheit (1)
- NOTES <Chirurgie> (1)
- Perforation <Medizin> (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 (1)
- Tissue Engineering (1)
- acute Respiratory Distress Syndrome (1)
- analgesics (1)
- anesthetics (1)
- anticoagulation (1)
- antiemetics (1)
- atrial fibrillation (1)
- bridging (1)
- clinical trial (1)
- critical care (1)
- cytokines (1)
- enhanced recovery after surgery (1)
- epidural analgesia (1)
- general anesthesia (1)
- growth differentiation factor 15 (1)
- immune response (1)
- impedance aggregometry; WHOLE-BLOOD THROMBOELASTOMETRY; DEFINITION; DISEASE (1)
- inflammation (1)
- intensive care medicine (1)
- laparoscopic surgery (1)
- low-molecular heparin (1)
- minimally invasive surgery (1)
- multimodal treatments (1)
- network meta-analysis (1)
- neurological complications (1)
- nutrient supplementation (1)
- oxidative stress (1)
- pandemia (1)
- point of care testing (1)
- postoperative bleeding (1)
- robotic surgery (1)
- selective outcome reporting (1)
- selen (1)
- small intestinal submucosa (1)
- systematic review (1)
- systematic review, (1)
- thromboelastometry (1)
- thromboembolism (1)
- trial registration (1)
- viral load (1)
- vomiting (1)
- zinc (1)
Institute
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (12)
- Frauenklinik und Poliklinik (3)
- Medizinische Klinik und Poliklinik I (3)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (2)
- Graduate School of Life Sciences (1)
- Institut für Experimentelle Biomedizin (1)
- Institut für Hygiene und Mikrobiologie (1)
- Institut für Klinische Epidemiologie und Biometrie (1)
- Institut für Virologie und Immunbiologie (1)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (1)
Background
The viral load and tissue distribution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain important questions. The current study investigated SARS-CoV-2 viral load, biodistribution and anti-SARS-CoV-2 antibody formation in patients suffering from severe corona virus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS).
Methods
This is a retrospective single-center study in 23 patients with COVID-19-induced ARDS. Data were collected within routine intensive care. SARS-CoV-2 viral load was assessed via reverse transcription quantitative polymerase chain reaction (RT-qPCR). Overall, 478 virology samples were taken. Anti-SARS-CoV-2-Spike-receptor binding domain (RBD) antibody detection of blood samples was performed with an enzyme-linked immunosorbent assay.
Results
Most patients (91%) suffered from severe ARDS during ICU treatment with a 30-day mortality of 30%. None of the patients received antiviral treatment. Tracheal aspirates tested positive for SARS-CoV-2 in 100% of the cases, oropharyngeal swabs only in 77%. Blood samples were positive in 26% of the patients. No difference of viral load was found in tracheal or blood samples with regard to 30-day survival or disease severity. SARS-CoV-2 was never found in dialysate. Serologic testing revealed significantly lower concentrations of SARS-CoV-2 neutralizing IgM and IgA antibodies in survivors compared to non-survivors (p = 0.009).
Conclusions
COVID-19 induced ARDS is accompanied by a high viral load of SARS-CoV-2 in tracheal aspirates, which remained detectable in the majority throughout intensive care treatment. Remarkably, SARS-CoV-2 RNA was never detected in dialysate even in patients with RNAemia. Viral load or the buildup of neutralizing antibodies was not associated with 30-day survival or disease severity.
Objectives
The severity of Coronavirus Disease 2019 (COVID-19) is largely determined by the immune response. First studies indicate altered lymphocyte counts and function. However, interactions of pro- and anti-inflammatory mechanisms remain elusive. In the current study we characterized the immune responses in patients suffering from severe COVID-19-induced acute respiratory distress syndrome (ARDS).
Methods
This was a single-center retrospective study in patients admitted to the intensive care unit (ICU) with confirmed COVID-19 between March 14th and May 28th 2020 (n = 39). Longitudinal data were collected within routine clinical care, including flow-cytometry of lymphocyte subsets, cytokine analysis and growth differentiation factor 15 (GDF-15). Antibody responses against the receptor binding domain (RBD) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike protein were analyzed.
Results
All patients suffered from severe ARDS, 30.8% died. Interleukin (IL)-6 was massively elevated at every time-point. The anti-inflammatory cytokine IL-10 was concomitantly upregulated with IL-6. The cellular response was characterized by lymphocytopenia with low counts of CD8+ T cells, natural killer (NK) and naïve T helper cells. CD8+ T and NK cells recovered after 8 to 14 days. The B cell system was largely unimpeded. This coincided with a slight increase in anti-SARS-CoV-2-Spike-RBD immunoglobulin (Ig) G and a decrease in anti-SARS-CoV-2-Spike-RBD IgM. GDF-15 levels were elevated throughout ICU treatment.
Conclusions
Massively elevated levels of IL-6 and a delayed cytotoxic immune defense characterized severe COVID-19-induced ARDS. The B cell response and antibody production were largely unimpeded. No obvious imbalance of pro- and anti-inflammatory mechanisms was observed, with elevated GDF-15 levels suggesting increased tissue resilience.